I really don't think that we will see double digits on the next run. JMO but the best way would be to release a fundamental change... i.e. a distribution date where product will be on the shelves and where. I think that we will get a projected revenue afterwards... but I really hope that this information is divided up and spaced one to two a week of information. The reason is that though we will spike we can quickly stabilize and then begin a slow climb then when something big drops... ie a JV partnership, Nasdaq uplisting or approval for orphan drug study for the MM product then it will shoot us through the roof. I would hope the company would be concerned about shorters. We are crazy oversold at this level. Not saying it won't go lower but even without news we are still oversold and not at actual value. I think we could see a 40 cent move just to get up back to being neutral. Again JMO. It's so close now... I'm tempted to go all in just because I believe we will see another pop but will never see these levels again. The next pop if timed right with information release we will see 10+million shares traded daily for a week, 2 or 3.... We will likely see profit taking on the way up which will make it hard to see the kind of pop we had before. But if sold to early they won't be able to get back in at the new low which could easily be at the $2 level with just an announcement of markets and date of distribution. I also think there is a strong chance we would see a move to the NasDaq by the end of the year. Again... all JMO
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links